Luigi Aurisicchio
Neomatrix Biotech (Italy) · 204 works · 4,169 citations · h-index 38
Top works
- Quantitative Optical Imaging of Primary Tumor Organoid Metabolism Predicts Drug Response in Breast Cancer
- SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
- Comparative expression pathway analysis of human and canine mammary tumors
- Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells
- Baculovirus Vectors Elicit Antigen-Specific Immune Responses in Mice
- Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system
- Liver-Specific Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis
- The promise of anti-ErbB3 monoclonals as new cancer therapeutics
- Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment
- Efficient induction of T‐cell responses to carcinoembryonic antigen by a heterologous prime‐boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA
- Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
- MMP11: A Novel Target Antigen for Cancer Immunotherapy
- The perfect personalized cancer therapy: cancer vaccines against neoantigens
- Epigenetic silencing of miR-145-5p contributes to brain metastasis
- A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
- Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
- DNA and Adenoviral Vectors Encoding Carcinoembryonic Antigen Fused to Immunoenhancing Sequences Augment Antigen-Specific Immune Response and Confer Tumor Protection
- Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
- CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge
- A Vaccine Targeting Telomerase Enhances Survival of Dogs Affected by B-cell Lymphoma